Heartbroken patients even with extension of the Soliris benefit
The health insurance standard of ‘Soliris (eculizumab)’, the only domestic PHN (paroxismal nocturnal hemoglobinuria) treatment, has been extended since the 1st. Now, patients who are pregnant up to 3 months after childbirth can be prescribed for Soliris with no relation of patients’ transfusion.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
